Glidewell Labs introduces line of bone grafting products

Glidewell Laboratories, a manufacturer medical devices, has announced it's launching a new line of bone grafting products called Newport Biologics.

The products include allograftic and alloplastic bone grafting options as well as resorbable barrier membranes and a wound dressing that is collagen based.

"The Newport Biologics line of bone grafting materials and resorbable barrier membranes represents the highest quality of regenerative products available," said Dr. Neil Park, director of clinical affairs for Glidewell Laboratories. "By assembling only the most versatile, effective, and frequently used regenerative materials the industry has to offer, we hope to provide clinicians a simplified buying experience, unparalleled value, and the confidence to efficiently and reliably treat the majority of grafting indications."

With the aging population needing more and more dental care that involves bone grafting for implant procedures, the demand for these products will continue to increase. The allograft originated from the University of Miami Tissue Bank and the resorbable membranes have been developed to give optimum handling to support the many different techniques physician use to place the bone grafts.

"We are very excited to add the Newport Biologics line to our growing portfolio of dental implant and restorative products," said Dave Casper, president of Prismatik Dentalcraft, the manufacturing division of Glidewell Laboratories. "We've solicited feedback from some of the top opinion leaders in implant dentistry to bring a focused line of regenerative products to our customers that can meet their bone grafting needs."